Filing Flows › Novavax (NVAX) › Net income
Novavax (NVAX) net income by quarter
Novavax's net income was $17.5M in Q4 2025 (fourth quarter 2025), -84% from Q2 2025. Over the last 3 quarters it ranged from $17.5M (Q4 2025) to $519M (Q1 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $17.5M | -84% | — |
| Q2 2025 | $107M | -79% | — |
| Q1 2025 | $519M | — | — |
Q4 2025 at a glance
Novavax, Q4 2025: revenue $147M (+67% year over year), operating margin 9.7%, net earnings $17.5M, operating cash flow −$39.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Novavax's net income?
Novavax's net income was $17.5M in Q4 2025 (fourth quarter 2025), -84% from Q2 2025.
How has Novavax's net income changed?
Over the last 3 quarters it ranged from $17.5M (Q4 2025) to $519M (Q1 2025).